#38: Hepatitis B in pregnancy screening, treatment, and prevention of vertical transmission

2010 Kubo, 2014, Prevention of vertical transmission of hepatitis B: an observational study, Ann Intern Med, 160, 828, 10.7326/M13-2529 Din, 2011, Estimating the number of births to hepatitis B virus-infected women in 22 states, 2006, Pediatr Infect Dis J, 30, 575, 10.1097/INF.0b013e31820cd65c Smith, 2012, The national perinatal hepatitis B prevention program, 1994-2008, Pediatrics, 129, 609, 10.1542/peds.2011-2866 Lin, 2009, Screening for hepatitis B virus infection in pregnant women: evidence for the US Preventive Services Task Force reaffirmation recommendation statement, Ann Intern Med, 150, 874, 10.7326/0003-4819-150-12-200906160-00012 2007, Viral hepatitis in pregnancy. ACOG Practice bulletin no. 86, Obstet Gynecol, 110, 941, 10.1097/01.AOG.0000263930.28382.2a Shaheen, 2010, The outcomes of pregnancy in patients with cirrhosis: a population-based study, Liver Int, 30, 275, 10.1111/j.1478-3231.2009.02153.x Hieber, 1977, Hepatitis and pregnancy, J Pediatr, 91, 545, 10.1016/S0022-3476(77)80499-X Jonas, 2009, Hepatitis B and pregnancy: an underestimated issue, Liver Int, 29, 133, 10.1111/j.1478-3231.2008.01933.x Lao, 2003, HBsAg carrier status and the association between gestational diabetes with increased serum ferritin concentration in Chinese women, Diabetes Care, 26, 3011, 10.2337/diacare.26.11.3011 Lao, 2007, Maternal hepatitis B infection and gestational diabetes mellitus, J Hepatol, 47, 46, 10.1016/j.jhep.2007.02.014 Lobstein, 2011, Prevalence of hepatitis B among pregnant women and its impact on pregnancy and newborn complications at a tertiary hospital in the eastern part of Germany, Digestion, 83, 76, 10.1159/000320455 Connell, 2011, Maternal hepatitis B and hepatitis C carrier status and perinatal outcomes, Liver Int, 31, 1163, 10.1111/j.1478-3231.2011.02556.x Mast, 2006, MMWR Recomm Rep, 55, 1 Yang, 2008, Elective cesarean section versus vaginal delivery for preventing mother to child transmission of hepatitis B virus–a systematic review, Virol J, 5, 100, 10.1186/1743-422X-5-100 Gartner, 2005, American Academy of Pediatrics Section on Breastfeeding. Breastfeeding and the use of human milk, Pediatrics, 115, 496, 10.1542/peds.2004-2491 Hill, 2002, Risk of hepatitis B transmission in breast-fed infants of chronic hepatitis B carriers, Obstet Gynecol, 99, 1049 de Martino, 1985, Should hepatitis B surface antigen positive mothers breast feed?, Arch Dis Child, 60, 972, 10.1136/adc.60.10.972 Ko, 1994, Amniocentesis in mothers who are hepatitis B virus carriers does not expose the infant to an increased risk of hepatitis B virus infection, Arch Gynecol Obstet, 255, 25, 10.1007/BF02390671 Chen, 2011, A nested case-control study of maternal-neonatal transmission of hepatitis B virus in a Chinese population, World J Gastroenterol, 17, 3640, 10.3748/wjg.v17.i31.3640 Song, 2007, Factors associated with immunoprophylaxis failure against vertical transmission of hepatitis B virus, Eur J Pediatr, 166, 813, 10.1007/s00431-006-0327-5 Gagnon, 2014, Prenatal invasive procedures in women with hepatitis B, hepatitis C, and/or human immunodeficiency virus infections, J Obstet Gynaecol Can, 36, 648, 10.1016/S1701-2163(15)30546-6 Towers, 2001, The presence of hepatitis B surface antigen and deoxyribonucleic acid in amniotic fluid and cord blood, Am J Obstet Gynecol, 184, 1514, 10.1067/mob.2001.114866 Yi, 2014, Risk of vertical transmission of hepatitis B after amniocentesis in HBs antigen-positive mothers, J Hepatol, 60, 523, 10.1016/j.jhep.2013.11.008 Beasley, 1983, Efficacy of hepatitis B immune globulin for prevention of perinatal transmission of the hepatitis B virus carrier state: final report of a randomized double-blind, placebo-controlled trial, Hepatology, 3, 135, 10.1002/hep.1840030201 Beasley, 1983, Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine, Lancet, 2, 1099, 10.1016/S0140-6736(83)90624-4 Chen, 1996, Seroepidemiology of hepatitis B virus infection in children: ten years of mass vaccination in Taiwan, JAMA, 276, 906, 10.1001/jama.1996.03540110060032 Chang, 1997, Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group, N Engl J Med, 336, 1855, 10.1056/NEJM199706263362602 Hwang, 1996, Comparison of three different hybridization assays in the quantitative measurement of serum hepatitis B virus DNA, J Virol Methods, 62, 123, 10.1016/S0166-0934(96)02093-9 Chen, 2006, Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level, JAMA, 295, 65, 10.1001/jama.295.1.65 Iloeje, 2007, Risk and predictors of mortality associated with chronic hepatitis B infection, Clin Gastroenterol Hepatol, 5, 921, 10.1016/j.cgh.2007.06.015 Liaw, 2004, Lamivudine for patients with chronic hepatitis B and advanced liver disease, N Engl J Med, 351, 1521, 10.1056/NEJMoa033364 Chang, 2010, Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B, Hepatology, 52, 886, 10.1002/hep.23785 Lok, 2009, Chronic hepatitis B: update 2009, Hepatology, 50, 661, 10.1002/hep.23190 Kitrinos, 2014, No detectable resistance to tenofovir disoproxil fumarate after 6 years of therapy in patients with chronic hepatitis B, Hepatology, 59, 434, 10.1002/hep.26686 Corsa, 2014, No resistance to tenofovir disoproxil fumarate through 96 weeks of treatment in patients with lamivudine-resistant chronic hepatitis B, Clin Gastroenterol Hepatol, 12, 2106, 10.1016/j.cgh.2014.05.024 Burk, 1994, Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load, J Infect Dis, 170, 1418, 10.1093/infdis/170.6.1418 del Canho, 1997, Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982-1992: protective efficacy and long-term immunogenicity, Vaccine, 15, 1624, 10.1016/S0264-410X(97)00080-7 Xu, 2009, Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicenter, randomized, double-blind, placebo-controlled study, J Viral Hepat, 16, 94, 10.1111/j.1365-2893.2008.01056.x Wiseman, 2009, Perinatal transmission of hepatitis B virus: an Australian experience, Med J Aust, 190, 489, 10.5694/j.1326-5377.2009.tb02524.x Pan, 2012, An algorithm for risk assessment and intervention of mother to child transmission of hepatitis B virus, Clin Gastroenterol Hepatol, 10, 452, 10.1016/j.cgh.2011.10.041 Zhu, 2003, A randomized control trial on interruption of HBV transmission in uterus, Chin Med J (Engl), 116, 685 Yue, 1999, Prevention of intrauterine infection by hepatitis B virus with hepatitis B immune globulin: efficacy and mechanism, Chin Med J (Engl), 112, 37 Li, 2004, Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection, World J Gastroenterol, 10, 3215, 10.3748/wjg.v10.i21.3215 Yuan, 2006, Antepartum immunoprophylaxis of three doses of hepatitis B immunoglobulin is not effective: a single-center randomized study, J Viral Hepat, 13, 597, 10.1111/j.1365-2893.2006.00738.x Lee, 2006, Effect of hepatitis B immunization in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis, BMJ, 332, 328, 10.1136/bmj.38719.435833.7C Brown, 2012, Hepatitis B virus and human immunodeficiency virus drugs in pregnancy: findings from the Antiretroviral Pregnancy Registry, J Hepatol, 57, 953, 10.1016/j.jhep.2012.06.031 Shi, 2010, Lamivudine in late pregnancy to interrupt in utero transmission of hepatitis B virus: a systematic review and meta-analysis, Obstet Gynecol, 116, 147, 10.1097/AOG.0b013e3181e45951 Greenup, 2014, Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus, J Hepatol, 61, 502, 10.1016/j.jhep.2014.04.038 Wu, 2015, Telbivudine prevents vertical transmission of hepatitis B virus from women with high viral loads: a prospective long-term study, Clin Gastroenterol Hepatol, 13, 1170, 10.1016/j.cgh.2014.08.043 Dunkelberg, 2014, Hepatitis B and C in pregnancy: a review and recommendations for care, J Perinatol, 34, 882, 10.1038/jp.2014.167 Fan, 2014, Cost-effectiveness of testing hepatitis B-positive pregnant women for hepatitis B e antigen or viral load, Obstet Gynecol, 123, 929, 10.1097/AOG.0000000000000124 Nayeri, 2012, Antenatal lamivudine to reduce perinatal hepatitis B transmission: a cost-effectiveness analysis, Am J Obstet Gynecol, 207, 231.e1, 10.1016/j.ajog.2012.06.001 Pirillo, 2015, Hepatitis B virus mother-to-child transmission among HIV-infected women receiving lamivudine-containing antiretroviral regimens during pregnancy and breastfeeding, J Viral Hepat, 22, 289, 10.1111/jvh.12301 Ehrhardt, 2015, Breastfeeding while taking lamivudine or tenofovir disoproxil fumarate: a review of the evidence, Clin Infect Dis, 60, 275, 10.1093/cid/ciu798 2012, EASL clinical practice guidelines: management of chronic hepatitis B virus infection, J Hepatol, 57, 167, 10.1016/j.jhep.2012.02.010 National Institute for Health and Care Excellence. Hepatitis B (chronic): diagnosis and management of chronic hepatitis B in children, young people and adults. NICE guidelines [CG165]. Available at: https://www.nice.org.uk/guidance/cg165/resources/guidance-hepatitis-b-chronic-pdf. Accessed Aug. 4, 2015. Sarkar, 2014, Ending vertical transmission of hepatitis B: the third trimester intervention, Hepatology, 60, 448, 10.1002/hep.27145